Top leadership in Beijing has faced difficult decisions over the previous weeks. Though new cases of COVID-19 continue to see a downward trend, much of this can be attributed to the fast and firm response of the officials, with the shutting down of crowded public spaces and city centres being just some examples of the measures taken. Senior figures in …
A university situated in Northern China announced earlier this week that they were ready to release their new testing kits for the novel coronavirus that is now known as COVID-19. Nankai University is based in the city of Tianjin and lies just shy of 70 miles southeast of Beijing. The century-old university collaborated with other top schools around the nation, …
A report released in February by US-based Research and Markets addresses the shift in China away from low volume, high value manufacturing as a major catalyst for the increasing growth rate of China’s pharmaceutical market. The country now holds, at minimum, an 8 – 10% market share globally. The report goes on to state that greater technological advancements could quickly …
What is the Coronavirus? The 2019-nCoV virus – more commonly known to the public as simply ‘coronavirus’ or ‘Wuhan coronavirus’ – has dominated international news over the recent weeks, as fears have mounted over the potential lethality of the disease. Fortunately, such fears appear to be thus far unfounded, as the disease sits at around a 2.2% mortality rate, with …
The Chinese pharmaceutical market sees another significant victory in recent weeks as it is announced that China has conditionally approved the first new Alzheimer’s drug to hit the global market in 17 years, and it will be distributed worldwide for long-term testing. The seaweed-derived drug GV-971, more colloquially known as Oligomannate, appears to improve cognition in patients with mild to …
- Page 1 of 2
- 1
- 2